ArticleActa pharmaceutica Sinica. B2022

Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays.

Chunlong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.